Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028

Segmented By Product Analysis (Somatostatin Analogs (SSA), Targeted Therapy, Others), By Site Analysis (Lungs, Pancreas, Colon, Small Intestine, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition

Published	Pages	Publisher	Report code
Mar 2023	117	TechSci Research	ASDR-618444

Published: Mar 2023 - Pages : 117 - Publisher : TechSci Research - Report code : ASDR-618444

1.F Hoffmann-La Roche AG
2.Bristol-Myers Squibb Co
3.Eli Lilly & Co
4.Novartis AG
5.Pfizer Inc
6.Amgen Inc
7.Exelixis Inc
8.Teva Pharmaceutical Industries Ltd
9.AVEO Pharmaceuticals Inc
10.Hutchison MediPharma Ltd

Global Neuroendocrine Tumor Treatment Market - 2023-2030

This report can be of interest as well:

Global Neuroendocrine Tumor Treatment Market - 2023-2030

Published: May, 2023 | Report code: ASDR-648375